Sanibel Captiva Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Sanibel Captiva Trust Company's VRTX Position: Q2 2026 in Review
Sanibel Captiva Trust Company opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 451 shares worth $224K. The stake represents 0.01% of the portfolio and ranks #440 among its holdings. This is a return to the name: Sanibel Captiva Trust Company previously reported a position in VRTX as recently as Q3 2025.
Sanibel Captiva Trust Company first reported a position in VRTX in Q3 2024 and has held it in 6 quarters since. The position peaked at $319K in Q1 2025. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Sanibel Captiva Trust Company held 451 shares of Vertex Pharmaceuticals worth $224K as of Q2 2026.
- Vertex Pharmaceuticals was a new Sanibel Captiva Trust Company position in Q2 2026.
- Vertex Pharmaceuticals made up 0.01% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #440 holding.
- Sanibel Captiva Trust Company first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
- Sanibel Captiva Trust Company's Vertex Pharmaceuticals position peaked at $319K in Q1 2025.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.